Eligible participants comprised women age 25 years or older with a diagnosis of breast or gynecologic cancers and receiving treatment at four participating hospitals. Participants were asked whether ...

Development and Validation of a Clinical Prediction Model for Paclitaxel Hypersensitivity Reaction on the Basis of Real-World Data: Pac-HSR Score Eligible participants comprised women age 25 years or ...

BERKELEY, Calif.--(BUSINESS WIRE)--Millie, a modern maternity clinic, today revealed promising maternal health outcomes from the first cohort of more than 150 births from its hybrid model that ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, which is approved by the FDA in ovarian cancer, and Jemperli for ...

As part of the CURE® Educated Patient® Gynecologic Cancers Summit, an expert explained the basics of biomarkers and the questions they raise. Patients can benefit from clinical trials in gynecologic ...

In 2024, the American Cancer Society estimates that uterine cancer will surpass ovarian cancer in total estimated number of deaths in the United States. That’s partly due to the progress made in ...

Minority patients with gynecologic cancers are more likely than White patients to receive treatment at academic facilities, a recent study found. Gynecologic cancer treatment also often requires ...

Spirituality significantly aids stress management in gynecologic cancer patients undergoing radiation therapy, with most patients rating faith as highly important. The FICA Spiritual History Tool ...